CK Life Sciences Intl (Holdings) Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CK Life Sciences Intl (Holdings) Inc with three other
companies in this sector in HONG KONG :
Tianjin Development Holdings Limited
sales of 4.55 billion Hong Kong Dollars [US$586.92 million]
of which 42%
China Grand Pharmaceutical and Healthcare Holdings Limited
(6.59 billion Hong Kong Dollars [US$850.32 million]
of which 65%
was Manufacture and sales of pharmaceutical ), and
China Shineway Pharmaceutical Group Limited
(3.07 billion Hong Kong Dollars [US$396.42 million]
of which 45%
CK Life Sciences Intl (Holdings) Inc reported sales of HK$4.97 billion (US$640.85 million)
December of 2019.
decrease of 5.1%
versus 2018, when the company's sales were HK$5.23 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, CK Life Sciences Intl (Holdings) Inc had sales
of HK$4.95 billion.
Contributing to the drop in overall sales was the 15.2% decline
in Agriculture Related, from HK$2.29 billion to HK$1.95 billion.
However, these declines were partially offset by the increase in sales of
Health (up 2.8% to HK$3.02 billion)
Unallocated (up 23.8% to HK$453,000.00 )